Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(65), 2021
DOI: 10.1128/aac.00084-21
Links
Tools
In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam
Journal article published in 2021 by
Abigail M. Rubio,
Ellen G. Kline,
Chelsea E. Jones,
Liang Chen 
,
Barry N. Kreiswirth,
M. Hong Nguyen,
Cornelius J. Clancy,
Vaughn S. Cooper ,
Ghady Haidar ,
Daria Van Tyne ,
Ryan K. Shields
,
Barry N. Kreiswirth,
M. Hong Nguyen,
Cornelius J. Clancy,
Vaughn S. Cooper ,
Ghady Haidar ,
Daria Van Tyne ,
Ryan K. Shields
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 
Abstract
We compared the in vitro susceptibility of multidrug-resistant Pseudomonas aeruginosa isolates collected before and after treatment-emergent resistance to ceftolozane-tazobactam. Median baseline and postexposure ceftolozane-tazobactam MICs were 2 and 64 μg/ml, respectively.